CTC immunotherapy trial shows new promise for prostate cancer patients

A clinical trial coordinated by the Cancer Trials Centre has found that men with advanced prostate cancer could benefit more from immunother [...]

(Publication) Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review

Rubio-San-Simón, A., Wilson, W., Sironi, G. et al.

(Publication) Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study

Gianmarco Leone, Yien Ning Sophia Wong, Robert J. Jones, Peter Sankey, Debra H. Josephs, Simon J. Crabb, Louise Harris, Anjali Zarkar, Andre [...]

Leukaemia treatment pioneered in CTC studies now approved for use in UK

A type of treatment which helps a cancer patient's immune system to fight blood cancer has been approved for use across the United Kingdom, [...]